News | January 28, 2022
Dr Reddy’s Q3FY22 PAT at Rs. 706 cr.
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended December 31, 2021
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended December 31, 2021
Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.
Torrent Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
Astec LifeSciences has reported its financial performance for the quarter ended December 31, 2021
The drug is to be supplied in 105 low and middle-income countries and 10 Indian firms are on the list
Biocon has reported consolidated financial results for the period ended December 31, 2021
This agreement allows Natco to expand access to Covid-19 medicines in 105 countries in generic name
They will commercialize molnupiravir in the international markets
The drug is aimed at treating Covid-19 patients with Acute Respiratory Distress Syndrome (ARDS)
Decisions reaffirm the ability of Biocon Biologics and Viatris to provide patient access to interchangeable Semglee
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
